Browse Category

SGX:O39 News 18 January 2026 - 22 January 2026

OCBC stock rises as new securities-financing push puts fee income in focus

OCBC stock rises as new securities-financing push puts fee income in focus

Singapore, Jan 22, 2026, 15:03 SGT — Regular session OCBC shares climbed Thursday, reflecting renewed investor interest in the bank’s expanding securities financing unit, which drives fee income and trading-related activities. The stock hit S$20.56, edging up from Wednesday’s close of S$20.44. (Investing) This move is significant as a direct wager on non-interest income, coming after bank stocks have largely…
OCBC stock price ticks up as Bank of Singapore names new CFO and investors eye Feb 25 results

OCBC stock price ticks up as Bank of Singapore names new CFO and investors eye Feb 25 results

Singapore, Jan 20, 2026, 15:12 SGT — Regular session Oversea-Chinese Banking Corp’s shares nudged higher Tuesday, bucking the downward trend among Singapore’s major banks. OCBC (O39.SGX) gained roughly 0.1%, trading at S$20.33 in the afternoon, up from Monday’s close of S$20.31. (Google) The real challenge won’t be today’s price action, but the update due next month. OCBC told the Singapore…
OCBC stock price slips after Bank of Singapore names new CFO; investors watch earnings next month

OCBC stock price slips after Bank of Singapore names new CFO; investors watch earnings next month

Singapore, January 19, 2026, 14:56 SGT — Regular session OCBC (SGX:O39) shares slipped Monday after naming Collins Chin, currently an OCBC executive, as global CFO of its private-banking arm, Bank of Singapore, effective immediately. By 2:48 p.m. Singapore time, the stock had fallen 0.49% to S$20.34, trading between S$20.27 and S$20.38 earlier, close to its 52-week peak of S$20.54. (SG…
OCBC stock price watch: shares close at S$20.44 ahead of Singapore CPI and Feb 25 results

OCBC stock price watch: shares close at S$20.44 ahead of Singapore CPI and Feb 25 results

Singapore, Jan 18, 2026, 15:04 (SGT) — Market closed. OCBC’s shares closed Friday 0.3% higher at S$20.44 as Singapore’s main index edged up before the weekend. The Straits Times Index gained 0.3% to 4,849.10, marking a 2.1% rise for the week, with the market closed Sunday. Jose Torres, senior economist at Interactive Brokers, noted that “bullish sentiment was revived on…

Stock Market Today

  • Pro Medicus Leverages US Market to Strengthen Competitive Edge in Health-Tech
    January 22, 2026, 5:15 AM EST. Pro Medicus (ASX:PME), known for its advanced radiology imaging software and AI capabilities, is strengthening its position in the US hospital market through long-term contracts. The company competes effectively against larger legacy vendors, supporting its premium valuation despite recent share price declines. Investor focus centers on Pro Medicus' ability to sustain contract wins, margins, and cash flow ahead of its February 12, 2026 earnings report. Market sentiment remains fragile amid high valuation risks and expectations. Divergent fair value estimates, ranging from A$68.65 to over A$500, highlight varying investor perspectives on its growth prospects and US footprint. Pro Medicus' premium positioning in the specialized health-tech arena underpins its broader investment narrative.
Go toTop